the activity is performed in a post-absorptive or postprandial state. Methods Twelve participants diagnosed with hyperglycemia, but not using anti-diabetic medication, underwent three test days in a randomized cross-over study; 1 control day without exercise, 1 day with 60 min of treadmill walking ending 30 min before breakfast, and 1 day with an identical bout of activity 30 min after the start of breakfast. Food intake was strictly standardized and venous blood for CRP, and sVCAM-1 analysis was sampled at standardized timepoints during the first 3.5 h after breakfast and once 24 h later. Results Merged data from the two exercise days showed that sVCAM-1 increased from baseline (4 ± 16 ng/mL) compared to the control condition (−28 ± 47 ng/mL, ES = 0.7, p = 0.024). There was no statistically significant difference in changes in sVCAM-1 levels between the two exercise test days. Exercise did not affect CRP values. Conclusion Moderate exercise increases sVCAM-1 in hyperglycemic individuals, whereas it does not affect CRP. 
Introduction
Systemic inflammation is involved in the development of a wide range of diseases, including cardiovascular disease, and in the progression of mild hyperglycemia into type 2 diabetes (Goldberg 2009 ). Exercise affects inflammation, and one bout of vigorous exercise initiates a cascade of both pro-inflammatory and anti-inflammatory events. These acute responses to exercise may be vital for the longterm adaptations to training, including the anti-inflammatory response associated with regular exercise (Allen et al. 2015) . In contrast to vigorous exercise, less is known about the effect of moderate exercise on systemic inflammation. In addition, the inflammatory response to exercise in hyperglycemic persons may be related to "time since food intake" since hyperglycemia itself results in systemic inflammation (Nappo et al. 2002) , and exercise after carbohydrate ingestion reduces postprandial hyperglycemia, while exercise prior to a meal does not (Colberg et al. 2009; Derave et al. 2007 ). It would, therefore, be interesting to investigate the acute effects of moderate physical exercise before and after a carbohydrate meal on inflammatory markers.
Numerous markers involved in the inflammatory process related to development of cardiovascular disease have been extensively studied, including C-reactive protein (CRP) and soluble vascular cell adhesion molecule 1 (sVCAM-1) (Goldberg 2009 ). The former is an acute-phase protein synthesized in response to homeostatic disturbances (Semple 2006) , which predicts the degree of cardiovascular risk, even in apparently healthy individuals (Emerging Risk Factors et al. 2010; Libby and Crea 2010; Semple 2006) . The adhesion molecule VCAM-1 is crucial for leucocyte migration into tissues, facilitating adhesion to endothelial cell membranes (Cook-Mills et al. 2011; Price and Loscalzo 1999) . A portion of the membrane expressed VCAM-1 is cleaved from the endothelial cells after cytokine activation, and can be measured in plasma as sVCAM-1 concentration (Pigott et al. 1992) , which predicts cardiovascular disease in hyperglycemic persons (Goldberg 2009 ). In the present study, we tested the hypothesis that moderate exercise acutely affects sVCAM-1 and CRP levels in hyperglycemic individuals and that these effects differ between exercises performed in the post-absorptive and postprandial states.
Methods

Participants
The study population consisted of individuals diagnosed with hyperglycemia, i.e., previously measured fasting venous plasma glucose ≥6.1 mmol/L and/or 2 h glucose tolerance ≥7.8 mmol/L, who were not using glucose-lowering medications and did not have autoimmune disease, cancer or other diseases directly and significantly affecting inflammatory status or metabolism, except for diabetes. Sample size calculations for a fixed effect model showed that n = 8 would be enough to obtain a p value <0.05, with power = 0.80, and an expected change in sVCAM-1 of 20 ± 20 ng/mL. Regarding the uncertainty in this calculation, we included 13 participants, of which one was excluded from the data set, because further examination of her patient journal after enrollment showed that she did not meet the inclusion criteria. Four women and eight men, all of European descent, completed the study and are included in the results. Their characteristics are summarized in Table 1 . Dosage and timing of intake of all drugs were kept stable during the study period, i.e., lipid-lowering therapy (n = 4), antithrombotic agents (n = 4), angiotensin II receptor antagonists (n = 2), and ACE inhibitors (n = 1). Median time from diagnosis of hyperglycemia to participation in the study was 8.5 months (IQR: 31 months). Seven of the participants had at least one parent or one sibling with diabetes. All women were postmenopausal. The participants reported that they had performed (mean ± SD): 219 ± 237 min of endurance or strength training and 177 ± 143 min of walking and 122 ± 49 min of lighter activity (like gardening and housework) per week for the last 3 months prior to study enrollment. Eight participants reported via questionnaire about their dietary habits, to be very conscious, and four somewhat conscious about their food intake.
Ethics statement
The Regional Ethics Committee (REK Sør-Øst, Norway) approved the study, and all participants gave their written informed consent. 
General design
The study was performed using a randomized cross-over design. Each subject carried out three test days ( Fig. 1) in a balanced order, with at least 6 days and no more than 21 days between each: 1 test day with physical exercise performed before breakfast (ExBr), 1 with identical exercise performed after breakfast (BrEx), and 1 day without exercise (CON). All experimental days were identical, except for the different exercise regimes or the lack thereof. Participants were sedentary on test days except for the exercise sessions, and all meals were standardized. All test days started in the morning, approximately at the same time for each participant (within 1 h), and blood samples were taken at standardized timepoints in the postprandial period after breakfast (until 3.5 h after start of breakfast) and after 24 h.
Exercise and nutrition
The participants were instructed not to perform any physical exercise during the last 3 days leading up to test days, and any eventually light activity during the first of these 3-day periods was recorded and repeated before the second and third test days. The exercise sessions in both ExBr and BrEx consisted of 60 min of treadmill walking at an individually standardized speed at 8% inclination. The individual speed was decided during a familiarization session >6 days before the first test, and defined as the speed corresponding to 12 at the Borg 6-20 RPE scale (Borg 1982) after 30 min of walking at 8% inclination. At the end of exercise at test days, the rating of perceived exertion was 12.0 ± 0.2 and 12.4 ± 0.2 (p = 0.021) on Borg scale, and blood lactate levels were 1.4 ± 0.2 and 1.7 ± 0.2 mmol/L (p = 0.038), for ExBr and BrEx, respectively. All other physical activity was limited to what was absolute necessary, like walking to the car and moving between living room, toilet, kitchen, and bedroom. Use of antioxidants or anti-inflammatory agents was not allowed during the last month leading up to study participation. We instructed the participants to standardize their diet 3 days prior to each test by writing down food intake in the days leading up to the first test day and repeating this regimen before the second and third test day. An absolute dietary standardization was performed from the evening 10 h before breakfast on each test day until 22 h after the breakfast. Standardization was achieved by repeating the diet eaten on the first test day both on the second and third test days. The participants were instructed to eat and register a self-chosen meal containing >30 g carbohydrate in the evening 10 h preceding breakfast. The breakfast contained 250 mL semi-skimmed milk and cornflakes corresponding to 1 g carbohydrate per kg body weight (1371 ± 966 KJ, 12 ± 6 g protein, 10 ± 4 g fat and 43 ± 27 g carbohydrate). Lunch (3.5 h after breakfast) contained a yogurt and selfchosen amounts of wholegrain crispbread, butter, cheese, and water. The participants could choose between several boil-in-bag dinner packages (salmon with rice and vegetables, chicken casserole, meatballs potatoes, and creamed peas or minced steak with stewed cabbage and potatoes; Fjordland AS, Norway) for dinner (7 h after breakfast). Leftovers were registered, and the corresponding food was removed on the second and the third test days. The evening meal (11 h after breakfast) consisted of a self-chosen amount of whole meal bread, butter, cheese, and skimmed milk that also was carefully registered and repeated. Macronutrient intake for each meal is given in online resource 1. The research team provided the subjects with all food for breakfast, lunch, dinner, and evening meal on test days.
The experiments were undertaken in our laboratory until the lunch meal was ingested, whereupon the participants were transported to their homes to stay for the remaining 22 h of the protocol. They had a checklist with details about the standardization, such as instructions about timing and amounts of food intake. Prior to test days, individual sessions were arranged with the participants, teaching them the importance of standardization and all procedures necessary for exact standardization. At the end of each test day, we had a dialog with each participant about how the standardization had been carried out with no deviations being reported.
Data sampling
Blood samples were drawn from an antecubital vein at baseline and thereafter 1.5, 2.5, 3.5 and 24 h after breakfast. In addition, blood was sampled at the end of the ExBr exercise bout (Fig. 1) . Blood was drawn into EDTA tubes and centrifuged immediately at 2600g for 12 min, before freezing. The plasma samples were thawed and freezed again prior to analysis. However, the results from the samples were found to be reliable, see online resource 2. Glucose and triglycerides were analyzed at Furst Medical Laboratories, Oslo, (Advia 2400 Chemistry System, Siemens Healthcare Diagnostics Inc). High-sensitivity CRP was determined by a solid-phase, chemiluminescent immunometric assay (Immulite 2000, Diagnostic Products Corporation, USA). In 35 out of 192 samples, CRP levels were below the minimum range of the assay, i.e. 0.2 mg/L. These samples were taken from 4 different subjects (6 + 5 + 16 + 8), and were set at the minimum range of the assay; 0.2 mg/L. We analyzed sVCAM-1 with commercially available ELISA kits (Human sVCAM-1/CD106 immunoassay Quantikine ELISA, R&D systems Inc, Minneapolis, USA). All analyses of CRP and sVCAM-1 from any particular subject were analyzed intra-assay. Intraassay coefficients of variation were 7% for CRP and 1% for sVCAM-1.
Data on oxygen consumption, respiratory exchange ratio (Oxycon Pro, Erich Jaeger, Hoechberg, Germany) and heart rate were retrieved for 10 min at several standardized timepoints until 3 h after breakfast (Fig. 1) , and mean values of the last 2 min of each sampling were used in the analyses. Blood lactate concentration (Biosen C-line, EKF-diagnostic GmbH, Germany) was measured from capillary blood 55 min into the exercise bouts and Borg 6-20 RPE (Borg 1982 ) was determined 5, 30, and 55 min into the exercise bouts.
Data analysis
Expenditure of energy and carbohydrate and fat utilization were calculated from VO 2 and RER values using a table given in McArdle, Katch and Katch textbook of exercise physiology (p. 188) (McArdle et al. 2010) , based on Zuntz et al. (1901) . To examine the effect of exercise independent of timing between exercise and food intake, we used merged data from the two exercise interventions. An effect was defined as a between test-day difference in change from baseline to subsequent measures. We did the statistical analysis with IBM SPSS statistics, version 22.0, using a linear mixed model. We utilized absolute values, used participant number as the repeated "subjects" variable and included random intercept in the model. Test day and time (baseline vs. subsequent sample) were used as fixed factors, and the residuals were checked for normality and homogeneity. The α-level was set at 0.05, and a p value <0.1 was considered as a tendency towards statistical significance. We calculated effect sizes (ES) for the effect of intervention and between interventions using Cohen's d z (Lakens 2013) , and interpreted the result according to Hopkins et al. (Hopkins et al. 2009 
Results
There were no differences in baseline values between the three test days for any of the measured variables (Table 2) . Heart rate, energy expenditure, carbohydrate utilization, and fat utilization increased during exercise (p < 0.001 for all, Fig. 2 ). These increases did not differ between ExBr and BrEx, except for carbohydrate utilization which tended to be higher for BrEx than ExBr, 0.83 ± 0.23 and 0.67 ± 0.32 g/min, respectively (p = 0.057).
The mean change from baseline in blood glucose and triglyceride concentrations did not differ between test days (p = 0.870 and p = 0.585, respectively). However, at 1.5 h, the blood glucose increase in BrEx (1.1 ± 1.0) was lower than in CON (3.0 ± 1.8 mmol/L, p = 0.004) and ExBr (3.1 ± 1.7 mmol/L, p = 0.001, Fig. 3a) . Triglyceride values increased from baseline to end of exercise within both ExBr (p = 0.005) and BrEx (p = 0.001, Fig. 3b ).
Merged data from ExBr and BrEx showed that the change in sVCAM-1 from baseline to all of the subsequent values was 32 ± 47 ng/ml higher after exercise compared to CON (p = 0.024, Fig. 3c ). This was a result of a nonsignificant increase after exercise of 4 ± 16 ng/mL and a decrease in CON of 28 ± 47 ng/mL (p = 0.014 within 1 3 CON). The effect size analysis showed a moderate effect of exercise on sVCAM-1 values (ES = 0.7). The concentration of sVCAM-1 increased with 28 ± 23 ng/mL from baseline to the end of exercise (p = 0.011, within exercise interventions). Compared to CON, sVCAM-1 values were also increased as a result of exercise at 3.5 h (13 ± 22 vs.
-46 ± 46 ng/mL from baseline in CON, p = 0.007) and 24 h (9 ± 24 vs. −33 ± 52 ng/mL in CON, p = 0.0016). No increase was present at 2.5 h compared to CON. Mean change in sVCAM-1 from baseline to subsequent measures for all three test days separately is presented in Fig. 3c . The difference between ExBr (−5 ± 19 ng/mL) and BrEx (16 ± 32 ng/mL) did not reach statistical significance (p = 0.193 for the difference of 21 ± 40 ng/ml). There was, however, a significant difference in change from baseline to the subsequent measures between CON and BrEx (p = 0.020) and a tendency towards significant difference between CON and ExBr (p = 0.099). The effect size analysis showed that the effect of the difference between the ExBr and BrEx was small (ES = 0.5). Individual sVCAM-1 results and absolute values for glucose, triglycerides, sVCAM-1, and CRP are shown in online resource 1.
There were no effect of intervention on CRP values, neither when exercise days were merged together and compared to CON (p = 0.921) nor when exercise interventions were compared to each other (p = 0.666). Mean changes in CRP from baseline to subsequent measures in all three test days are presented in Fig. 3d . The effect size analysis showed a trivial effect of exercise on CRP values (ES = 0.1 vs. CON), and the effect of the difference between the ExBr and BrEx was small (ES = 0.3).
Discussion
The main finding in this study was that the levels of sVCAM-1 were increased after exercise compared to the control condition in hyperglycemic participants, but this was not the case for CRP, which remained unchanged. The latter is in agreement with a few previous studies exploring the effect of moderate exercise on CRP in healthy persons (Davis et al. 2008; Markovitch et al. 2008; Mendham et al. 2011) . In contrast, CRP was found to increase in blood after 50 min cycling at 65% of VO 2max in subjects with coronary artery disease (Lara Fernandes et al. 2011) . The response of severe exercise on CRP has been more extensively studied, with both vigorous eccentric and non-eccentric muscle exercise leading to increased levels (Semple 2006) , peaking around 24 h post-exercise (Semple et al. 2004; Weight et al. 1991) .
A decrease in the sVCAM-1 level during the control condition seems to be the main cause of the observed difference between the exercise and the control condition. It is plausible that the decrease in sVCAM-1 during the control condition was a result of inactivity. With regard to the selfreported activity level prior to study, the control condition represented a decrease in activity level, and the exercise test days may have reflected "real life" more closely than the control condition for those participants. The differences in sVCAM-1 levels can be explained by production of reactive oxygen species in the mitochondria when metabolism is altered, since increased oxidative stress augments inflammatory processes (Allen et al. 2015) .
Our findings concerning sVCAM-1 are in accordance with previous studies on healthy and diseased persons. Different types of exercise have entailed increased sVCAM-1 levels, ranging from relatively short bouts of moderate intensity (Lara Fernandes et al. 2011 ) and high intensity (Brevetti et al. 2001 ) to a 246 km running competition (Bartzeliotou et al. 2007 ). However, some conflicting results exist (Gabriel et al. 2012; Smith et al. 2000) .
Hyperglycemic excursions, which typically occur after a carbohydrate rich meal in individuals with reduced glucose tolerance or diabetes, potentially increases markers of systemic inflammation, sVCAM-1 included, via oxidative stress (Ceriello 2005; Nappo et al. 2002; Sampson et al. 2002; Standl et al. 2011) . However, the test day with the highest numeric sVCAM-1 values had the lowest postprandial glycemia after breakfast, i.e., the day with postprandial exercise. It is, therefore, likely that the sVCAM-1 increase in our study was mediated primarily by other factors than the hyperglycemia per se. Indeed, the results from the control day indicate that the carbohydrate rich breakfast did not increase s-VCAM1 levels. This could be because the carbohydrate content of the breakfast was too low or the participants in our study had only mild or moderate hyperglycemia, since the inflammatory response depends on the severity of hyperglycemia (Nappo et al. 2002; Quagliaro et al. 2005) . Therefore, the current results cannot be generalized to persons with more severe dysregulation of glucose metabolism. It is also important to keep in mind that insulin levels and insulin sensitivity might influence responses to exercise. Insulin has been reported to have anti-oxidative (Monnier et al. 2010 ) and anti-inflammatory effects (Dandona et al. 2009) , and there are large differences in insulin action among different hyperglycemic individuals.
The increase in sVCAM-1 after postprandial exercise was numerically larger than after post-absorptive exercise, but the difference did not reach statistical significance. We cannot rule out that this might be a type 2 error caused by a larger than expected variation in the sVCAM-1 response. Alternatively, the lower baseline value followed by numerically larger sVCAM response after postprandial exercise could suggest a regression towards means.
Exercise-mediated cortisol secretion, which suppress several parts of the immune system, is exaggerated by glycogen depletion and attenuated by carbohydrate ingestion (Nieman 1999) , which might explain why postabsorptive exercise eventually entails lower sVCAM-1 responses than postprandial exercise. However, the observed carbohydrate and fat utilization does not support any effect via glycogen depletion and cortisol. If glycogen stores were depleted as a result of the exercise bout in the post-absorptive but not the postprandial state, a lower carbohydrate utilization should have occurred after the post-absorptive exercise (Devlin and Horton 1985) . Therefore, 1 h of moderate exercise may be too light and/ or short to entail a substantial immunosuppressive effect of cortisol, even if it is performed in the post-absorptive state.
It is important to gain knowledge about how physical activity affects systemic inflammation and health, especially in individuals prone to cardiovascular disease, like the hyperglycemic persons in the present study. It is, however, hard to interpret the observed post-exercise increases in sVCAM-1 with regard to the clinical significance, since the present study only considered acute effects of exercise. Nevertheless, the acute inflammatory response to exercise may be vital for the adaptations to exercise training and also the anti-inflammatory response to exercise in the long term (Allen et al. 2015) . Since the lack of statistical significance between sVCAM-1 responses to post-absorptive and postprandial exercise might be a type 2 error, we cannot conclude that such difference do not exist. Future studies on exercise and inflammation should, therefore, still pay attention to dietary standardization and realize that dietary intake may affect the results. As the results of the present study entailed only trivial to moderate effect sizes, futurerelated studies should also address more extreme dietary challenges, participants with severe hyperglycemia and/ or higher doses of exercise. The finding that CRP is not affected acutely by prior moderate exercise might also be useful in the interpretation of "borderline" CRP results, if, e.g., the patient was walking to the clinic.
Conclusion
Moderate exercise increases sVCAM-1 in hyperglycemic individuals, whereas it does not affect CRP. It appears that there are no substantial differences in the sVCAM-1 response depending on whether the exercise is performed in the post-absorptive or postprandial state.
